journal article·2018-05

Photothermally Controlled MHC Class I Restricted CD8+ T‐Cell Responses Elicited by Hyaluronic Acid Decorated Gold Nanoparticles as a Vaccine for Cancer Immunotherapy

Fengqiang Cao, Mengmeng Yan, Yijia Liu, Lanxia Liu, Guilei Ma

Advanced Healthcare Materials· Volume 7· Issue 10
Publisher page

Abstract

Abstract Cancer vaccines aim to induce a strong major histocompatibility complex class I (MHC‐I)‐restricted CD8+ cytotoxic T‐cell response, which is an important prerequisite for successful cancer immunotherapy. Herein, a hyaluronic acid (HA) and antigen (ovalbumin, OVA)‐decorated gold nanoparticle (AuNPs)‐based (HA‐OVA‐AuNPs) vaccine is developed for photothermally controlled cytosolic antigen delivery using near‐infrared (NIR) irradiation and is found to induce antigen‐specific CD8+ T‐cell responses. Chemical binding of thiolated HA and OVA to AuNPs facilitates antigen uptake of dendritic cells via receptor‐mediated endocytosis. HA‐OVA‐AuNPs exhibit enhanced NIR absorption and thermal energy translation. Cytosolic antigen delivery is then permitted through the photothermally controlled process of local heat‐mediated endo/lysosome disruption by laser irradiation along with reactive oxygen species generation, which helps to augment proteasome activity and downstream MHC I antigen presentation. Consequently, the HA‐OVA‐AuNPs nanovaccine can effectively evoke a potent anticancer immune response in mice under laser irradiation. This NIR‐responsive nanovaccine is promising as a potent vaccination method for improving cancer vaccine efficacy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Nanoplatforms for cancer theranostics · Immune Cell Function and Interaction

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Tianjin Key Laboratory of Biomaterials Institute of Biomedical Engineering Peking Union Medical College & Chinese Academy of Medical Sciences 236# Baidi Road Tianjin 300192 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Tianjin City

References (41)

Show source-provided references
1. Delany I. · EMBO Mol. Med. · 2014 · 6 · 7010.1002/emmm.201403876 ↗
2. 10.1111/j.1751-7915.2011.00276.x10.1111/j.1751-7915.2011.00276.x ↗
3. 10.1038/nbt126110.1038/nbt1261 ↗
4. 10.1172/JCI8000910.1172/JCI80009 ↗
5. 10.1016/j.ejps.2011.08.01610.1016/j.ejps.2011.08.016 ↗
6. 10.1038/nri325410.1038/nri3254 ↗
7. 10.1038/icb.2008.310.1038/icb.2008.3 ↗
8. 10.1016/j.coi.2007.12.00210.1016/j.coi.2007.12.002 ↗
9. Wang Y. · Adv. Healthcare Mater. · 2014 · 3 · 3670
10. 10.1016/j.jconrel.2014.03.04110.1016/j.jconrel.2014.03.041 ↗
11. 10.1021/nn506679310.1021/nn5066793 ↗
12. 10.1016/j.addr.2008.03.01610.1016/j.addr.2008.03.016 ↗
13. 10.1039/C1CS15237H10.1039/C1CS15237H ↗
14. 10.1021/acs.jpcc.5b1123210.1021/acs.jpcc.5b11232 ↗
15. 10.1007/s10103-007-0470-x10.1007/s10103-007-0470-x ↗
16. 10.1016/j.addr.2015.12.01810.1016/j.addr.2015.12.018 ↗
17. 10.1039/C4CC07155G10.1039/C4CC07155G ↗
18. 10.1021/ja204578e10.1021/ja204578e ↗
19. 10.1002/adfm.20120166310.1002/adfm.201201663 ↗
20. 10.1016/j.addr.2015.11.01110.1016/j.addr.2015.11.011 ↗
21. 10.1038/gt.2013.7710.1038/gt.2013.77 ↗
22. 10.1152/physrev.00052.200910.1152/physrev.00052.2009 ↗
23. 10.1242/jcs.106.1.36510.1242/jcs.106.1.365 ↗
24. 10.1021/acsami.6b0113510.1021/acsami.6b01135 ↗
25. 10.1021/la062064e10.1021/la062064e ↗
26. 10.1016/j.ijpharm.2017.04.06010.1016/j.ijpharm.2017.04.060 ↗
27. 10.1016/j.biomaterials.2016.11.05610.1016/j.biomaterials.2016.11.056 ↗
28. 10.1002/adfm.20140388510.1002/adfm.201403885 ↗
29. 10.1038/3258810.1038/32588 ↗
30. 10.1038/nri100110.1038/nri1001 ↗
31. 10.1128/CMR.9.4.53210.1128/CMR.9.4.532 ↗
32. 10.1016/j.coi.2003.11.00410.1016/j.coi.2003.11.004 ↗
33. 10.3390/biom404099410.3390/biom4040994 ↗
34. 10.1074/mcp.M110.00692410.1074/mcp.M110.006924 ↗
35. 10.1016/j.cell.2010.07.03610.1016/j.cell.2010.07.036 ↗
36. 10.1016/j.biomaterials.2015.11.04010.1016/j.biomaterials.2015.11.040 ↗
37. 10.1038/cddis.2011.1210.1038/cddis.2011.12 ↗
38. 10.1016/j.biomaterials.2011.11.02210.1016/j.biomaterials.2011.11.022 ↗
39. 10.1016/j.eurpolymj.2015.07.03610.1016/j.eurpolymj.2015.07.036 ↗
40. 10.1039/c1py00060h10.1039/c1py00060h ↗
41. 10.1016/j.jconrel.2015.04.01010.1016/j.jconrel.2015.04.010 ↗